Search results
Dr. Daniel Geynisman Named New Editor-in-Chief for | Newswise
Newswise· 6 days agoGeynisman, MD, is being announced as the new Editor-in-Chief for JNCCN—Journal of the National...
Oncology nurse develops game to help seniors manage cancer care at home
NBC 10 Providence· 4 days ago“When somebody is typically diagnosed with cancer, you know, it's a very overwhelming experience,"...
Centra brings back docs to hematology and oncology clinic
RockinghamNow.com, Eden and Reidssville· 5 days agoCentra Health announced both Dr. Cecilia MacCallum and Dr. Emaculate Tebit will be joining the...
Incyte expands Delaware footprint with downtown Wilmington properties By Investing.com
Investing.com· 6 hours agoThe King Street building, slated to open in 2026, is expected to house over 400 employees, including...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 6 hours agoDive Insight: AstraZeneca has reinvented itself over the past decade, shifting from its prior focus...
How an Ohio mother's love of running got her through a cancer diagnosis and pregnancy
USA TODAY via Yahoo News· 5 hours agoTwo weeks later, I was diagnosed.” She reached out to mutual friends to reconnect with the woman,...
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post...
Benzinga· 17 hours agoToday AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing ...
An inside look at the transition of Centra's cancer care, after new clinic opened in April
ABC 13 Lynchburg· 1 day ago"We weren't sure what we were stepping into," said Centra patient Jack Mangus. "I was definitely a...
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
Digital Journal· 11 hours ago(NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals ...
Insider Sale: Chief Medical Officer of ALX Oncology Holdings Inc
Guru Focus· 6 days agoThe transaction was filed on May 15, 2024, as reported in the SEC Filing. ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused ...